This antihistamin drug is also evaluated in Alzheimers (Phase-III) due to its potential neuroprotective effects:
http://www.physorg.com/news184860820.html
--Frank
Dimbeon success in Huntingtons trial
Dimbeon success in Huntingtons trial
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.